Onkologie. 2020:14(2):74-77 | DOI: 10.36290/xon.2020.012

Epidemiology and prognosis of malignant tumours in pregnancy

Martin Hruda
Gynekologicko-porodnická klinika FNKV, Praha

The incidence of malignancy in pregnancy has long been a marginal issue; however, in the last decades, its incidence has been growing with the increasing age of expectant mothers. Malignant disease in pregnancy is a complication for approximately 20-40/100,000 pregnant women. Cervical cancer, breast cancer, melanoma, and haematological malignancies are among the most common diagnoses. In the majority of cases, the prognosis of malignant disease discovered during pregnancy does not differ from that of unpregnant patients. In many malignancies, however, early symptoms may be masked due to pregnancy changes, resulting in them being diagnosed at a later stage, particularly in the case of breast carcinoma or melanoma. When choosing the treatment strategy, it must be kept in mind that two lives are being influenced; therefore, centres specialised in this type of therapy should be in charge of doing that.

Keywords: epidemiology, prognosis, incidence, malignancy, pregnancy.

Published: June 2, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hruda M. Epidemiology and prognosis of malignant tumours in pregnancy. Onkologie. 2020;14(2):74-77. doi: 10.36290/xon.2020.012.
Download citation

References

  1. ÚZIS. Novotvary 2000. ČR. Praha: Ústav zdravotnických informací a statistiky ČR; 2004.
  2. ÚZIS. Novotvary 2016. ČR. Praha: Ústav zdravotnických informací a statistiky ČR; 2019.
  3. ÚZIS. Rodička a novorozenec 2014-2015. Praha: Ústav zdravotnických informací a statistiky ČR; 2017.
  4. Halaška M, Rob L, a kol. Onkologická onemocnění během těhotenství. Mladá fronta: Praha, 2015: 232s.
  5. Lee YY, Roberts CL, Dobbins T, Stavrou E, Black K, Morris J, et al. Incidence and outcomes of pregnancy-associated cancer in Australia, 1994-2008: a population-based linkage study. An Int J Obstet and Gynecol 2012; 119(13): 1572-1582. Go to original source... Go to PubMed...
  6. Eibye S, Kjaer SK, Mellemkjaer L: Incidence of pregnancy-associated cancer in Denmark, 1977-2006. Am J Obstet Gynecol 2013; 122(3): 608-617. Go to original source... Go to PubMed...
  7. Smith LH, Danielsen B, Allen ME, Cress R. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol 2003; 189(4): 1128-1135. Go to original source... Go to PubMed...
  8. Parazzini F, Franchi M, Tavani A, Negri E, Peccatori FA. Frequency of Pregnancy Related Cancer: A Population Based Linkage Study in Lombardy, Italy. Int J Gynecol Cancer. 2017; 27(3): 613-619. Go to original source... Go to PubMed...
  9. Stensheim H, Møller B, van Dijk T, Fosså SD: Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 2009; 27(1): 45-51. Go to original source... Go to PubMed...
  10. Halaska MJ, Uzan C, Han SN, et al. Characteristics of patients with cervical cancer during pregnancy: a multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy [published online ahead of print, 2019 Mar 20]. Int J Gynecol Cancer. 2019. Go to original source...
  11. Azim HA. Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies. Cancer Treat review 2012; 38(7): 834-842. Go to original source... Go to PubMed...
  12. Lishner M, Zemlickis D, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Maternal and foetal outcome following Hodgkin's disease in pregnancy. BrJ Cancer 1992; 65: 114-117. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.